EN
中文
EN
Who We Are
Newsroom
Innovation
Products
Investor Relations
Careers
Contact Us
Information Disclosure
Home
>
Investor Relations
>
Information Disclosure
H Share
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2019
Monthly Return of Equity Issuer on Movements in Securities
VOLUNTARY ANNOUNCEMENT - PARTIAL DISPOSAL OF SHARES BY SUBSTANTIAL SHAREHOLDERS
2019 ANNUAL REPORT
INSIDE INFORMATION RECOMBINANT NOVEL CORONAVIRUS VACCINE (ADENOVIRUS TYPE 5 VECTOR) APPROVED FOR CLINICAL TRIAL
INSIDE INFORMATION
NOTICE OF BOARD MEETING
INSIDE INFORMATION PRE-IND REVIEW APPLICATION FOR RECOMBINANT NOVEL CORONAVIRUS VACCINE (ADENOVIRUS TYPE 5 VECTOR) AND LAUNCH OF PRE-SCREENING OF HEALTHY VOLUNTEERS
Monthly Return of Equity Issuer on Movements in Securities
Monthly Return of Equity Issuer on Movements in Securities
1
44
45
46
47
48
53